Show simple item record

dc.creatorJongwattanapisan, P
dc.creatorTerajima, M
dc.creatorMiguez, PA
dc.creatorQuerido, W
dc.creatorNagaoka, H
dc.creatorSumida, N
dc.creatorGurysh, EG
dc.creatorAinslie, KM
dc.creatorPleshko, N
dc.creatorPerera, L
dc.creatorYamauchi, M
dc.date.accessioned2021-01-14T17:16:29Z
dc.date.available2021-01-14T17:16:29Z
dc.date.issued2018-12-01
dc.identifier.issn2045-2322
dc.identifier.issn2045-2322
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/4652
dc.identifier.other29728612 (pubmed)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/4670
dc.description.abstract© 2018 The Author(s). We have reported that recombinant biglycan (BGN) core protein accelerates bone formation in vivo by enhancing bone morphogenetic protein (BMP)-2 function. The purpose of the present study was to identify the specific domain ("effector") within the BGN core protein that facilitates BMP-2 osteogenic function. Thus, we generated various recombinant and synthetic peptides corresponding to several domains of BGN, and tested their effects on BMP-2 functions in vitro. The results demonstrated that the leucine-rich repeats 2-3 domain (LRR2-3) of BGN significantly enhanced the BMP-2 induced Smad1/5/9 phosphorylation, osteogenic gene expression, and alkaline phosphatase activity in myogenic C2C12 cells. Furthermore, addition of LRR2-3 to osteoblastic MC3T3-E1 cells accelerated in vitro mineralization without compromising the quality of the mineral and matrix. These data indicate that LRR2-3 is, at least in part, responsible for BGN's ability to enhance BMP-2 osteogenic function, and it could be useful for bone tissue regeneration.
dc.format.extent7022-
dc.language.isoen
dc.relation.haspartScientific Reports
dc.relation.isreferencedbySpringer Science and Business Media LLC
dc.rightsCC BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAnimals
dc.subjectBiglycan
dc.subjectBone Morphogenetic Protein 2
dc.subjectCalcification, Physiologic
dc.subjectCell Line
dc.subjectCells, Cultured
dc.subjectMice
dc.subjectModels, Molecular
dc.subjectOsteogenesis
dc.subjectPeptides
dc.subjectProtein Binding
dc.subjectProtein Conformation
dc.subjectProtein Interaction Domains and Motifs
dc.subjectRats
dc.subjectRecombinant Fusion Proteins
dc.subjectSignal Transduction
dc.subjectSpectroscopy, Fourier Transform Infrared
dc.subjectStructure-Activity Relationship
dc.titleIdentification of the effector domain of biglycan that facilitates BMP-2 osteogenic function
dc.typeArticle
dc.type.genreJournal Article
dc.relation.doi10.1038/s41598-018-25279-x
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.creator.orcidPleshko, Nancy|0000-0001-8656-3936
dc.date.updated2021-01-14T17:16:25Z
refterms.dateFOA2021-01-14T17:16:30Z


Files in this item

Thumbnail
Name:
Identification of the effector ...
Size:
1.766Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

CC BY
Except where otherwise noted, this item's license is described as CC BY